University of Pittsburgh HEALTH SCIENCES@PITT | HSLS | PITT HOME | FIND PEOPLE | CONTACT US |  
  Pharmacology Department at the University of Pittsburgh  
Pharmacology
Pharmacology
Pharmacology

Billy Day PhD

 

Professor of Pharmaceutical Sciences and Chemistry Director, Proteomics Core Lab

10017 BST3
3501 Fifth Avenue,, PA 15260

Phone: 412-648-9706
Email: bday@pitt.edu
Fax: 412.624.1850

Links for this Faculty Member

 

 
 

Research Description:

Dr. Day's lab is interested in the discovery and development of drugs to treat solid tumors. The lab uses computational chemistry, synthetic medicinal chemistry, biochemical methods, cell biology, molecular techniques, radio- and stable isotope labeling syntheses, mass spectrometry and animal models to discover new agents then study their mechanisms of action. Projects include: design and synthesis of truncated versions of the potent microtubule stabilizer discodermolide; high-throughput biochemical and cell based screening of parallel and combinatorial libraries of anti-tubulin and anti-dynein agents; characterization of changes in signal transduction cascades by synthetic agents; parallel solid- and solution-phase synthesis of 1,1-dichloro-2,2,3-triarylcyclopropanes and 2,3-diarylcyclopropyl phenyl ketones as estrogen receptor modulators; and quantitative structure-activity relationship analyses of synthetic libraries. The lab also collaborates extensively both in and outside the university in the areas of computational design/discovery, synthesis, redox biochemistry and both small molecule and macromolecule mass spectrometry (proteomics).

Education:

B.S. (Chemistry & Biology), Oklahoma City University, 1982
Ph.D. (Medicinal Chemistry), University of Oklahoma, 1988
Postdoctoral Fellow, Massachusetts Institute of Technology, 1988-91

Important Publications:

  • Buey, R.M., Calvo, E., Barasoain, I., Pineda, O., Edler, M.C., Matesanz, R., Cerezo, G., Vanderwal, C.D., Day, B.W., sorensen, E.J., Lopez, J.A., Andreu, J. M., Hamel, E., Diaz, J.F. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites. Nature Chem. Biol. 2007, 3, 117-125., 2007
  • Beckner, M.E., Zhang, Z., Agostino, N.R., Day, B.W., Pollack, I.F. Albumin marks pseudopodia of astrocytoma cells responding to hepatocyte growth factor or serum. Lab. Invest. 2006, 86, 1103-1114., 2006
  • Hamel, E., Day, B.W., Miller, J.J., Jung, M.K., Northcote, P.T., Ghosh, A.K., Curran, D.P., Cushman, M., Nicolaou, K.C., Paterson, I., Sorensen, E.J. Synergistic effects of peloruside and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly. Mon. Pharmacol. 2006, 70, 1555-1564., 2006
  • Fan, Y., Schreiber, E.M., Giorgianni, A., Yalowich, J.C., Day, B.W. Myeloperoxidase-catalyzed metabolism of etoposide to its quinone and glutathione adduct forms in HL60 cells. Chem. Res. Toxicol. 2006, 19, 937-943, 2006
  • Zhu, G., Yang, F., Balachandran, R., Hook, P., Vallee, R., Curran, D.P., Day, B.W. Synthesis and biological evaluation of purealin and analogues as cytoplasmic dynein heavy chain inhibitors. J. Med. Chem. 2006, 49, 2063-2076., 2006
  • Kangani, C.O., Kelley, D.E., Day, B.W. One-pot direct synthesis of oxazolines, benzoxazoles, and oxadiazoles from carboxylic acids using the Deoxo-Fluor reagent. Tetrahedron Lett. 2006, 47, 6497-6499., 2006
 

 

  © University of Pittsburgh. All rights reserved.
Contact Webmaster.